List of publications

Dr Alyson Muldrew

  • Beatty S, Nolan JM, Muldrew KA, Woodside J, Stevenson MR, Chakravarthy U. Visual outcome after antioxidant supplementation. Ophthalmology. 2013 Mar;120(3):645.
  • Beatty S, Chakravarthy U, Nolan JM, Muldrew KA, Woodside JV, Denny F, Stevenson MR. Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. Ophthalmology. 2013 Mar;120(3):600-6.
  • Silvestri G, Williams MA, McAuley C, Oakes K, Sillery E, Henderson DC, Ferguson S, Silvestri V, Muldrew KA. Drusen prevalence and pigmentary changes in Caucasians aged 18-54 years. Eye (Lond). 2012 Oct;26(10):1357-62.
  • Hogg RE, McKay GJ, Hughes AE, Muldrew KA, Chakravarthy U. Genotype-phenotype associations in neovascular age-related macular degeneration. Retina. 2012 Oct;32(9):1950-8.
  • Reeves BC, Harding SP, Langham J, Grieve R, Tomlin K, Walker J, Guerriero C, Carpenter J, Patton WP, Muldrew KA, Peto T, Chakravarthy U. Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK. Health Technol Assess. 2012;16(6).
  • Lai Y, Grattan J, Shi Y, Young G, Muldrew A, Chakravarthy U. Functional and morphologic benefits in early detection of neovascular age-related macular degeneration using the preferential hyperacuity perimeter. Retina. 2011 Sep;31(8):1620-6.
  • Harding SP, Tomlin K, Reeves BC, Langham J, Walker J, Carpenter J, Grieve R, Patton WP, Muldrew KA, Peto T, Chakravarthy U; Verteporfin Photodynamic Therapy Cohort Study Group. Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomes. Ophthalmology. 2009 Dec;116(12):e1-8.
  • Neelam K, Muldrew A, Hogg R, Stack J, Chakravarthy U, Beatty S. Grading of age-related maculopathy: slit-lamp biomicroscopy versus an accredited grading center. Retina. 2009 Feb;29(2):192-8.
  • Chakravarthy U, Walsh AC, Muldrew A, Updike PG, Barbour T, Sadda SR. Quantitative fluorescein angiographic analysis of choroidal neovascular membranes: validation and correlation with visual function. Invest Ophthalmol Vis Sci. 2007 Jan;48(1):349-54.
  • Hart PM, Stevenson MR, Montgomery AM, Muldrew KA, Chakravarthy U. Further validation of the Daily Living Tasks Dependent on Vision: identification of domains. Br J Ophthalmol. 2005 Sep;89(9):1127-30.
  • Ali F, Chan WC, Stevenson MR, Muldrew KA, Chakravarthy U. Morphometric analysis of angiograms of exudative lesions in age-related macular degeneration. Arch Ophthalmol. 2004 May;122(5):710-5.
  • Hogg R, Curry E, Muldrew A, Winder J, Stevenson M, McClure M, Chakravarthy U. Identification of lesion components that influence visual function in age related macular degeneration. Br J Ophthalmol. 2003 May;87(5):609-14.
  • Abugreen S, Muldrew KA, Stevenson MR, VanLeeuwen R, DeJong PT, Chakravarthy U. CNV subtype in first eyes predicts severity of ARM in fellow eyes. Br J Ophthalmol. 2003 Mar;87(3):307-11.